Detalhe da pesquisa
1.
Effect of High-Dose Posaconazole on Serum Levels in Adult Patients with Hematologic Malignancy.
Antimicrob Agents Chemother
; 65(12): e0123021, 2021 11 17.
Artigo
em Inglês
| MEDLINE | ID: mdl-34570643
2.
Carbapenem versus Cefepime or Piperacillin-Tazobactam for Empiric Treatment of Bacteremia Due to Extended-Spectrum-ß-Lactamase-Producing Escherichia coli in Patients with Hematologic Malignancy.
Antimicrob Agents Chemother
; 63(2)2019 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-30509935
3.
Outcomes and metrics for antimicrobial stewardship: survey of physicians and pharmacists.
Clin Infect Dis
; 59 Suppl 3: S108-11, 2014 Oct 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-25261537
4.
Assessing appropriateness of antimicrobial therapy: in the eye of the interpreter.
Clin Infect Dis
; 59 Suppl 3: S154-61, 2014 Oct 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-25261542
5.
Breaking down the barriers: challenges with development and implementation of an industry-sponsored antimicrobial stewardship data collection and analysis tool.
Clin Infect Dis
; 59 Suppl 3: S179-84, 2014 Oct 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-25261545
6.
Serum Levels of Crushed Posaconazole Delayed-Release Tablets.
Antimicrob Agents Chemother
; 63(5)2019 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-30803970
7.
In vitro assessment and multicenter cohort study of comparative nephrotoxicity rates associated with colistimethate versus polymyxin B therapy.
Antimicrob Agents Chemother
; 58(5): 2740-6, 2014 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-24566187
8.
Implementation of an Automated Antibiotic Time-out at a Comprehensive Cancer Center.
Open Forum Infect Dis
; 11(5): ofae235, 2024 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-38798895
9.
Use of daptomycin to treat infections with methicillin-resistant Staphylococcus aureus isolates having vancomycin minimum inhibitory concentrations of 1.5 to 2 µg/mL.
Ann Pharmacother
; 47(12): 1654-65, 2013 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-24259618
10.
Significant Publications on Infectious Diseases Pharmacotherapy in 2020.
J Pharm Pract
; 36(2): 394-406, 2023 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-34449277
11.
Should Piperacillin-Tazobactam Be Used as Definitive Therapy against Enterobacteriaceae Harboring Inducible AmpC ß-Lactamases?
Antimicrob Agents Chemother
; 61(9)2017 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-28839082
12.
Significant Publications on Infectious Diseases Pharmacotherapy in 2019.
J Pharm Pract
; 34(5): 800-813, 2021 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-32935641
13.
Significant Publications on Infectious Diseases Pharmacotherapy in 2018.
J Pharm Pract
; 32(5): 546-557, 2019 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-31327285
14.
Significant Publications on Infectious Diseases Pharmacotherapy in 2016.
J Pharm Pract
; 31(5): 469-480, 2018 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-28847232
15.
Dosing strategy to allow continued therapy with daptomycin after asymptomatic increases in creatine kinase levels.
Am J Health Syst Pharm
; 71(13): 1101-7, 2014 Jul 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-24939500